English
Technology & science
Then 99 kr. / month. Cancel anytime.
Dr. Ben Synth examines conflicting evidence on Ozempic and pancreatitis risk, comparing observational studies showing nine-fold increases against randomized trials finding no elevated rates. He explains why the answer depends on which data you trust and your personal risk factors, helping listeners make informed decisions about GLP-1 medications. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.
Choose your subscription
Most popular
Limited Offer
Premium
20 hours of audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
2 months for 19 kr.
Then 99 kr. / month
Premium Plus
Unlimited audiobooks
Podcasts only on Podimo
No ads in Podimo shows
Cancel anytime
Start 7 days free trial
Then 129 kr. / month
2 months for 19 kr. Then 99 kr. / month. Cancel anytime.